- Home
- ARBB vs CLRB Comparison
ARBB vs CLRB Comparison
Compare ARBB & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBB
- CLRB
- Stock Information
- Founded
- ARBB 1997
- CLRB 2002
- Country
- ARBB Singapore
- CLRB United States
- Employees
- ARBB N/A
- CLRB N/A
- Industry
- ARBB EDP Services
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- ARBB Technology
- CLRB Health Care
- Exchange
- ARBB Nasdaq
- CLRB Nasdaq
- Market Cap
- ARBB 11.9M
- CLRB 12.5M
- IPO Year
- ARBB 2023
- CLRB N/A
- Fundamental
- Price
- ARBB $6.96
- CLRB $0.29
- Analyst Decision
- ARBB Strong Buy
- CLRB Hold
- Analyst Count
- ARBB 1
- CLRB 2
- Target Price
- ARBB $20.00
- CLRB N/A
- AVG Volume (30 Days)
- ARBB 17.5K
- CLRB 36.3M
- Earning Date
- ARBB 06-27-2025
- CLRB 08-12-2025
- Dividend Yield
- ARBB N/A
- CLRB N/A
- EPS Growth
- ARBB N/A
- CLRB N/A
- EPS
- ARBB N/A
- CLRB N/A
- Revenue
- ARBB $24,425,491.00
- CLRB N/A
- Revenue This Year
- ARBB N/A
- CLRB N/A
- Revenue Next Year
- ARBB N/A
- CLRB N/A
- P/E Ratio
- ARBB N/A
- CLRB N/A
- Revenue Growth
- ARBB N/A
- CLRB N/A
- 52 Week Low
- ARBB $3.22
- CLRB $0.22
- 52 Week High
- ARBB $18.60
- CLRB $3.15
- Technical
- Relative Strength Index (RSI)
- ARBB 43.03
- CLRB 44.51
- Support Level
- ARBB $6.48
- CLRB $0.32
- Resistance Level
- ARBB $7.46
- CLRB $0.47
- Average True Range (ATR)
- ARBB 0.63
- CLRB 0.07
- MACD
- ARBB 0.14
- CLRB -0.01
- Stochastic Oscillator
- ARBB 75.92
- CLRB 9.50
About ARBB ARB IOT Group Limited
ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.